) The incidence of esophageal adenocarcinoma (EA), a rapidly fatal cancer with 5-year survival of less than 10 percent, has risen more then 350 percent over the past 20 years. Neoplastic progression in Barrett's esophagus (BE), the precursor to EA, is characterized by progressive genetic instability, including mutations (p53, p16), promoter hypermethylation (p16), aneuploidy and chromosomal instability (LOH, deletions and amplifications). Barrett's esophagus is an excellent model of human neoplastic progression because endoscopic surveillance is recommended, permitting serial samples to be evaluated over time in the same patient. Shortened telomeres, p53 and p16 inactivation occur before EA. We hypothesize that telomere shortening causes chromosomal instability in BE as has been proposed in model systems. However, relationships among p16/p53 inactivation, reactivation of telomerase, and chromosomal instability during human neoplastic progression are largely unknown. In this proposal, I will investigate the hypothesis that telomere shortening, abrogation of p16 and p53 function and telomerase reactivation interact to mediate chromosomal instability in BE. We propose to measure telomerase activity in BE samples in 325 patients from the Seattle Barrett's Esophagus Cohort, an extremely well characterized cohort for whom p53 and p16 status and flow cytometric data are already known. We will use clonal ordering to determine relationships among p53 inactivation, p16 inactivation, telomerase reactivation and the development of chromosomal instability, using alterations on chromosome 18 as a model of instability. Chromosome 18 is an appropriate model because it is frequently (75 percent of cases) altered in EA (LOH events, amplifications and deletions) and these alterations are selected before the development of cancer. The methods used in these analyses will include TRAP assays to measure telomerase activity and microsatellite LOH and microarray comparative genomic hybridization (CGH) to assess chromosomal instability. The results from these analyses will be of interest to both clinical and basic researchers in studying EA and other cancers.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Academic/Teacher Award (ATA) (K07)
Project #
5K07CA089147-02
Application #
6514817
Study Section
Subcommittee G - Education (NCI)
Program Officer
Gorelic, Lester S
Project Start
2001-04-01
Project End
2006-03-31
Budget Start
2002-04-01
Budget End
2003-03-31
Support Year
2
Fiscal Year
2002
Total Cost
$94,973
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
075524595
City
Seattle
State
WA
Country
United States
Zip Code
98109
Paulson, Thomas G; Maley, Carlo C; Li, Xiaohong et al. (2009) Chromosomal instability and copy number alterations in Barrett's esophagus and esophageal adenocarcinoma. Clin Cancer Res 15:3305-14
Paulson, Thomas G; Galipeau, Patricia C; Xu, Lianjun et al. (2008) p16 mutation spectrum in the premalignant condition Barrett's esophagus. PLoS One 3:e3809
Chao, Dennis L; Sanchez, Carissa A; Galipeau, Patricia C et al. (2008) Cell proliferation, cell cycle abnormalities, and cancer outcome in patients with Barrett's esophagus: a long-term prospective study. Clin Cancer Res 14:6988-95
Li, Xiaohong; Self, Steven G; Galipeau, Patricia C et al. (2007) Direct inference of SNP heterozygosity rates and resolution of LOH detection. PLoS Comput Biol 3:e244
Lai, Lisa A; Paulson, Thomas G; Li, Xiaohong et al. (2007) Increasing genomic instability during premalignant neoplastic progression revealed through high resolution array-CGH. Genes Chromosomes Cancer 46:532-42
Kraly, James R; Jones, Megan R; Gomez, David G et al. (2006) Reproducible two-dimensional capillary electrophoresis analysis of Barrett's esophagus tissues. Anal Chem 78:5977-86
Paulson, Thomas G; Xu, Lianjun; Sanchez, Carissa et al. (2006) Neosquamous epithelium does not typically arise from Barrett's epithelium. Clin Cancer Res 12:1701-6
Maley, Carlo C; Galipeau, Patricia C; Finley, Jennifer C et al. (2006) Genetic clonal diversity predicts progression to esophageal adenocarcinoma. Nat Genet 38:468-73
Maley, Carlo C; Galipeau, Patricia C; Li, Xiaohong et al. (2004) The combination of genetic instability and clonal expansion predicts progression to esophageal adenocarcinoma. Cancer Res 64:7629-33
Maley, Carlo C; Galipeau, Patricia C; Li, Xiaohong et al. (2004) Selectively advantageous mutations and hitchhikers in neoplasms: p16 lesions are selected in Barrett's esophagus. Cancer Res 64:3414-27

Showing the most recent 10 out of 12 publications